Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2005-001959-38-DK
EUCTR2005-001959-38-DK
Active, not recruiting
Phase 1

Fase II trial with gemcitabine and oxaliplatin in patients with unknown primary tumours - UPT - unfit

Gedske Daugaard0 sites39 target enrollmentJune 16, 2005
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsTo test the effect of Gemcitabine and axaliplatin in patients with unknown primary tumours and performance 2 or age 66 to 75
DrugsGemzarOxaliplatin

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
To test the effect of Gemcitabine and axaliplatin in patients with unknown primary tumours and performance 2 or age 66 to 75
Sponsor
Gedske Daugaard
Enrollment
39
Status
Active, not recruiting
Last Updated
9 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 16, 2005
End Date
TBD
Last Updated
9 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
Gedske Daugaard

Eligibility Criteria

Inclusion Criteria

  • •Unknown primary tumour
  • •Performance 2 or age 66 to 75
  • •Measurable lesion by RECIST
  • •Expected life time more than 12 weeks
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range:
  • •F.1\.2 Adults (18\-64 years) yes
  • •F.1\.2\.1 Number of subjects for this age range
  • •F.1\.3 Elderly (\>\=65 years) yes
  • •F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • •Performance 0 or 1 and age below 66
  • •another known cancer disease

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 2
Phase II study of gemcitabine and oxaliplatin (GEMOX) in gemcitabine refractory advanced biliary tract cancer (JASPAC02)gemcitabine refractory advanced biliary tract cancer
JPRN-UMIN000003650Japan Adjuvant Study Group of Pancreatic Cancer (JASPAC)40
Terminated
Phase 2
A Phase II Trial of Gemcitabine and Oxaliplatin for Triple Negative Metastatic Breast CancerBreast Cancer
NCT00674206Emory University6
Completed
Phase 2
Clinical Studies of Gemcitabine-OxaliplatinMedulloblastomaCentral Nervous System TumorsNeuroblastomaOsteosarcoma
NCT00407433Gustave Roussy, Cancer Campus, Grand Paris156
Completed
Phase 2
Efficacy Study of GEMOX Combination and Vinorelbine in NSCL PatientsNon Small Cell Lung Cancer
NCT00271271Sanofi40
Completed
Phase 2
Gemcitabine With Oxaliplatin (GEMOX) in Patients With Advanced Hepatocellular Carcinoma After Failure of Sorafenib TreatmentHepatocellular Carcinoma, Unresectable, Advanced
NCT05517239Yonsei University32